Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Hamann

Showing results (131-140 of 160) with videos related to

Pageof 16
Sort By:
Allergy|November 19, 2017
Poor agreement in questionnaire-based diagnostic criteria for adult atopic dermatitis is a challenge when examining cardiovascular comorbidityY M F Andersen, A Egeberg, C R Hamann, et al.
Cancer Immunology, Immunotherapy : CII|December 13, 2006
CD20-specific antibody-targeted chemotherapy of non-Hodgkin's B-cell lymphoma using calicheamicin-conjugated rituximabJohn F Dijoseph, Maureen M Dougher, Douglas C Armellino, et al.
The British Journal of Dermatology|June 11, 2026
Risk of major adverse cardiovascular events in patients with chronic hand eczema from the Danish National Patient RegisterMaria O Christensen, Johan Sieborg, Ida Vittrup, et al.
Journal of the American Academy of Dermatology|December 11, 2013
Spectrometric analysis of mercury content in 549 skin-lightening products: is mercury toxicity a hidden global health hazard?Carsten R Hamann, Waranya Boonchai, Liping Wen, et al.
Pharmacology|January 1, 1985
Effects of phenobarbital and SKF-525A on in vitro hepatic metabolism of verapamil and nifedipineS R Hamann, T G Tan, K E Kaltenborn, et al.
Contact Dermatitis|August 1, 2015
Jewellery: alloy composition and release of nickel, cobalt and lead assessed with the EU synthetic sweat methodDathan Hamann, Jacob P Thyssen, Carsten R Hamann, et al.
Contemporary Clinical Trials Communications|December 6, 2021
Iterative development and pilot testing of an intervention fidelity monitoring plan for the enhanced, electronic health record-facilitated pragmatic clinical trial: Implications for training and protocol integrityLinda L Chlan, Jennifer L Ridgeway, Cindy S Tofthagen, et al.
Contact Dermatitis|July 8, 2016
Assessment of chromium(VI) release from 848 jewellery items by use of a diphenylcarbazide spot testDavid Bregnbak, Jeanne D Johansen, Dathan Hamann, et al.
Dermatitis : Contact, Atopic, Occupational, Drug|June 23, 2018
Electrochemical Screening Spot Test Method for Detection of Nickel and Cobalt Ion Release From Metal SurfacesMorten S Jellesen, Christian Bang Olsen, Samine Ruff, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 7, 2006
Antitumor efficacy of a combination of CMC-544 (inotuzumab ozogamicin), a CD22-targeted cytotoxic immunoconjugate of calicheamicin, and rituximab against non-Hodgkin's B-cell lymphomaJohn F DiJoseph, Maureen M Dougher, Lyka B Kalyandrug, et al.
Pageof 16

Showing results (131-140 of 160) with videos related to

Sort By:
Pageof 16
Allergy|November 19, 2017
Poor agreement in questionnaire-based diagnostic criteria for adult atopic dermatitis is a challenge when examining cardiovascular comorbidityY M F Andersen, A Egeberg, C R Hamann, et al.
Cancer Immunology, Immunotherapy : CII|December 13, 2006
CD20-specific antibody-targeted chemotherapy of non-Hodgkin's B-cell lymphoma using calicheamicin-conjugated rituximabJohn F Dijoseph, Maureen M Dougher, Douglas C Armellino, et al.
The British Journal of Dermatology|June 11, 2026
Risk of major adverse cardiovascular events in patients with chronic hand eczema from the Danish National Patient RegisterMaria O Christensen, Johan Sieborg, Ida Vittrup, et al.
Journal of the American Academy of Dermatology|December 11, 2013
Spectrometric analysis of mercury content in 549 skin-lightening products: is mercury toxicity a hidden global health hazard?Carsten R Hamann, Waranya Boonchai, Liping Wen, et al.
Pharmacology|January 1, 1985
Effects of phenobarbital and SKF-525A on in vitro hepatic metabolism of verapamil and nifedipineS R Hamann, T G Tan, K E Kaltenborn, et al.
Contact Dermatitis|August 1, 2015
Jewellery: alloy composition and release of nickel, cobalt and lead assessed with the EU synthetic sweat methodDathan Hamann, Jacob P Thyssen, Carsten R Hamann, et al.
Contemporary Clinical Trials Communications|December 6, 2021
Iterative development and pilot testing of an intervention fidelity monitoring plan for the enhanced, electronic health record-facilitated pragmatic clinical trial: Implications for training and protocol integrityLinda L Chlan, Jennifer L Ridgeway, Cindy S Tofthagen, et al.
Contact Dermatitis|July 8, 2016
Assessment of chromium(VI) release from 848 jewellery items by use of a diphenylcarbazide spot testDavid Bregnbak, Jeanne D Johansen, Dathan Hamann, et al.
Dermatitis : Contact, Atopic, Occupational, Drug|June 23, 2018
Electrochemical Screening Spot Test Method for Detection of Nickel and Cobalt Ion Release From Metal SurfacesMorten S Jellesen, Christian Bang Olsen, Samine Ruff, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 7, 2006
Antitumor efficacy of a combination of CMC-544 (inotuzumab ozogamicin), a CD22-targeted cytotoxic immunoconjugate of calicheamicin, and rituximab against non-Hodgkin's B-cell lymphomaJohn F DiJoseph, Maureen M Dougher, Lyka B Kalyandrug, et al.
Pageof 16